Table 1.
SARS-CoV-2 Variant | Non-Omicron | Omicron and Sub-Lineages | ||||
---|---|---|---|---|---|---|
Total Cases (n) | 30 | 37 | ||||
Gender | Male | Female | Male (%) | Male | Female | Male (%) |
22 | 7 | 75.9 | 23 | 14 | 62.2 | |
Age (years old) | ||||||
10–19 | 2 | 2 | 50.0 | 0 | 3 | 0.0 |
20–29 | 3 | 0 | 100.0 | 4 | 2 | 66.7 |
30–39 | 2 | 2 | 50.0 | 2 | 1 | 66.7 |
40–49 | 8 | 3 | 72.7 | 5 | 4 | 55.6 |
50–59 | 6 | 0 | 100.0 | 11 | 3 | 78.6 |
60–69 | 0 | 0 | - | 0 | 1 | 0.0 |
≥70 | 0 | 0 | - | 1 | 0 | 100.0 |
not available | 1 | |||||
Clinical manifestations | ||||||
Non-specific symptoms of infection | 7 | 3 | 70.0 | 17 | 12 | 58.6 |
COVID-19 symptoms | 12 | 5 | 70.6 | 18 | 13 | 58.1 |
Previous COVID-19 diagnosis | 6 | 0 | 100.0 | 4 | 7 | 36.4 |
Previous SARS-CoV-2 positive swab | 5 | 1 | 83.3 | 4 | 7 | 36.4 |
Chronic diseases | 3 | 0 | 100.0 | 7 | 8 | 46.7 |
Contact tracing | ||||||
Contact with COVID-19 sick people in the previous 14 days | 9 | 4 | 69.2 | 13 | 12 | 52.0 |
Contact with positive people to the SARS-CoV-2 swab in the previous 14 days | 11 | 4 | 73.3 | 14 | 13 | 51.9 |
not available | 1 |